Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Alto Neuroscience (ANRO) Debt Ratio (2023 - 2026)

Alto Neuroscience has reported Debt Ratio over the past 4 years, most recently at 0.06 for Q1 2026.

  • Quarterly results put Debt Ratio at 0.06 for Q1 2026, down 50.0% from a year ago — trailing twelve months through Mar 2026 was 0.06 (down 50.0% YoY), and the annual figure for FY2025 was 0.09, up 57.1%.
  • Debt Ratio reached 0.06 in Q1 2026 per ANRO's latest filing, down from 0.09 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.14 in Q3 2025 and bottomed at 0.05 in Q1 2024.
  • Median Debt Ratio over the past 4 years was 0.07 (2026), compared with a mean of 0.09.
  • The largest annual shift saw Debt Ratio surged 160.71% in 2025 before it tumbled 50.0% in 2026.
  • Over 4 years, Debt Ratio stood at 0.11 in 2023, then plummeted by 49.26% to 0.06 in 2024, then soared by 57.1% to 0.09 in 2025, then tumbled by 36.08% to 0.06 in 2026.
  • Business Quant data shows Debt Ratio for ANRO at 0.06 in Q1 2026, 0.09 in Q4 2025, and 0.14 in Q3 2025.